Gene therapy using ovine adenoviral vectors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/70 (2006.01) C12N 15/861 (2006.01)

Patent

CA 2229631

A method of gene therapy in a human subject comprising administering to the subject a viral vector comprising a DNA molecule including a nucleic acid sequence encoding the genome of an ovine adenovirus capable of infecting human cells or functionally equivalent nucleic acid sequence or portion thereof and at least one nucleic acid sequence encoding a gene to be expressed in the cell, such that the viral vector infects at least one cell of the subject and the infected cell expresses the gene.

L'invention porte sur un procédé de thérapie génique destiné à l'homme et consistant à administrer à un patient un vecteur viral comprenant une molécule d'ADN comportant une séquence d'acide nucléique codant pour le génome d'un adénovirus ovin capable d'infecter des cellules humaines, ou une séquence d'acide nucléique fonctionnellement équivalente ou l'une de ses parties, et au moins une séquence d'acide nucléique codant pour un gène s'exprimant dans la cellule, de manière à ce que le vecteur viral infecte au moins l'une des cellules du patient et que la cellule infectée exprime le gène.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Gene therapy using ovine adenoviral vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene therapy using ovine adenoviral vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene therapy using ovine adenoviral vectors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2058124

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.